DEVONIAN HEALTH GROUP INC (GSD.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:GSD • CA2518348008

10 CAD
0 (0%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GSD. GSD was compared to 33 industry peers in the Pharmaceuticals industry. GSD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GSD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year GSD has reported negative net income.
  • GSD had a negative operating cash flow in the past year.
  • In the past 5 years GSD always reported negative net income.
  • In the past 5 years GSD reported 4 times negative operating cash flow.
GSD.CA Yearly Net Income VS EBIT VS OCF VS FCFGSD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M -6M

1.2 Ratios

  • GSD has a Return On Assets of -44.73%. This is in the lower half of the industry: GSD underperforms 75.76% of its industry peers.
  • The Return On Equity of GSD (-72.55%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
ROA -44.73%
ROE -72.55%
ROIC N/A
ROA(3y)-22.64%
ROA(5y)-21.36%
ROE(3y)-37.09%
ROE(5y)-35.39%
ROIC(3y)N/A
ROIC(5y)N/A
GSD.CA Yearly ROA, ROE, ROICGSD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • GSD has a Gross Margin (38.40%) which is comparable to the rest of the industry.
  • GSD's Gross Margin has improved in the last couple of years.
  • GSD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.24%
GM growth 5YN/A
GSD.CA Yearly Profit, Operating, Gross MarginsGSD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GSD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GSD has about the same amout of shares outstanding than it did 1 year ago.
  • GSD has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GSD has been reduced compared to a year ago.
GSD.CA Yearly Shares OutstandingGSD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GSD.CA Yearly Total Debt VS Total AssetsGSD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • GSD has an Altman-Z score of 164.99. This indicates that GSD is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 164.99, GSD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that GSD is not too dependend on debt financing.
  • GSD has a better Debt to Equity ratio (0.01) than 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 164.99
ROIC/WACCN/A
WACC8.63%
GSD.CA Yearly LT Debt VS Equity VS FCFGSD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

  • GSD has a Current Ratio of 1.44. This is a normal value and indicates that GSD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.44, GSD perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • A Quick Ratio of 1.43 indicates that GSD should not have too much problems paying its short term obligations.
  • GSD has a Quick ratio of 1.43. This is in the better half of the industry: GSD outperforms 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.43
GSD.CA Yearly Current Assets VS Current LiabilitesGSD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for GSD have decreased strongly by -22454.24% in the last year.
  • The Revenue for GSD has decreased by -23.32% in the past year. This is quite bad
  • Measured over the past years, GSD shows a very strong growth in Revenue. The Revenue has been growing by 61.56% on average per year.
EPS 1Y (TTM)-22454.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13658.54%
Revenue 1Y (TTM)-23.32%
Revenue growth 3Y117.11%
Revenue growth 5Y61.56%
Sales Q2Q%-82.81%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSD.CA Yearly Revenue VS EstimatesGSD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GSD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSD.CA Price Earnings VS Forward Price EarningsGSD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSD.CA Per share dataGSD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GSD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DEVONIAN HEALTH GROUP INC

TSX-V:GSD (2/9/2026, 7:00:00 PM)

10

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)12-11
Earnings (Next)04-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.1%
Ins Owner ChangeN/A
Market Cap1.66B
Revenue(TTM)18.52M
Net Income(TTM)-6.97M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 89.59
P/FCF N/A
P/OCF N/A
P/B 172.85
P/tB 353.21
EV/EBITDA N/A
EPS(TTM)-2.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.11
BVpS0.06
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.73%
ROE -72.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.4%
FCFM N/A
ROA(3y)-22.64%
ROA(5y)-21.36%
ROE(3y)-37.09%
ROE(5y)-35.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.24%
GM growth 5YN/A
F-Score4
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.43
Altman-Z 164.99
F-Score4
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)1.89%
Cap/Depr(5y)3.25%
Cap/Sales(3y)0.03%
Cap/Sales(5y)0.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22454.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13658.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.32%
Revenue growth 3Y117.11%
Revenue growth 5Y61.56%
Sales Q2Q%-82.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-256.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.14%
OCF growth 3YN/A
OCF growth 5YN/A

DEVONIAN HEALTH GROUP INC / GSD.CA FAQ

What is the fundamental rating for GSD stock?

ChartMill assigns a fundamental rating of 2 / 10 to GSD.CA.


Can you provide the valuation status for DEVONIAN HEALTH GROUP INC?

ChartMill assigns a valuation rating of 0 / 10 to DEVONIAN HEALTH GROUP INC (GSD.CA). This can be considered as Overvalued.


Can you provide the profitability details for DEVONIAN HEALTH GROUP INC?

DEVONIAN HEALTH GROUP INC (GSD.CA) has a profitability rating of 1 / 10.